DNA marker predicts platinum drug response in breast, ovarian cancer
Scientists from Brigham and Women's Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive "triple negative" breast cancers and certain ovarian cancers will ...
Mar 22, 2012
0
0